WASHINGTON, Aug 20 (Reuters) - BioForm Medical Inc, a medical aesthetics company, said on Monday it was planning an initial public offering of as much as $115 million in common stock. JPMorgan, Piper Jaffray, CIBC World Markets and Jefferies & Company will underwrite the IPO, according to a preliminary offering document filed with the U.S. Securities and Exchange Commission.
